Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
8 drugs for “Colorectal Cancer”
Approved 1
- SotorasibAMGEN INCColorectal Cancer (CRC); Metastatic Colorectal Cancer
Phase 3 7
- INCA33890INCYTE CORPCRC (Colorectal Cancer)
- MRTX849Mirati Therapeutics, Inc.Advanced Colorectal Cancer; Metastatic Colorectal Cancer
- PetosemtamabGENMAB A/SColorectal Cancer; Left-sided Colorectal Cancer
- PumitamigBRISTOL MYERS SQUIBB COUntreated, Unresectable, or Metastatic Colorectal Cancer
- TAS-102Merck & Co., Inc.Colorectal Cancer
- Telisotuzumab adizutecanAbbVie Inc.Colorectal Cancer
- XL092EXELIXIS, INC.Colorectal Cancer
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.